Erratum: Prostaglandin e 2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase (Nature Communications (2013) 4 (1685) DOI: 10.1038/ncomms2684);Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase

Nature Communications

Volumn 4, Issue , 2013, Pages

  Yao, Chengcan ^a,b,d   Hirata, Takako ^a,b   Soontrapa, Kitipong ^a   Ma, Xiaojun ^a   Takemori, Hiroshi ^c   Narumiya, Shuh ^a,b  

^a KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON RECEPTOR 1; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; T LYMPHOCYTE RECEPTOR;

CELL ORGANELLE; DISEASE PREVALENCE; DRUG; IMMUNE RESPONSE; SIGNALING;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH1 CELL; UPREGULATION;

EID: 84877746121     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3315     Document Type: Erratum

References (47)

1. Zhu, J. & Paul, W. E. CD4 T cells: fates, functions, and faults. Blood 112, 1557-1569 (2008).
2. Liao, W., Lin, J., Wang, L., Li, P. & Leonard, W. J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 12, 551-559 (2011).
3. Smith-Garvin, J. E., Koretzky, G. A. & Jordan, M. S. T Cell Activation. Annu. Rev. Immunol. 27, 591-619 (2009).
4. Bourne, H. R. et al. Modulation of inflammation and immunity by cyclic AMP. Science 184, 19-28 (1974).
5. Kammer, G. M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9, 222-229 (1988).
6. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113 (1991).
7. Moore, A. R. & Willoughby, D. A. The role of cAMP regulation in controlling inflammation. Clin. Exp. Immunol. 101, 387-389 (1995).
8. Mosenden, R. & Tasken, K. Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells. Cell Signal 23, 1009-1016 (2011).
9. H17 cell expansion. Nat. Med. 15, 633-640 (2009).
10. 4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. Br. J. Pharmacol. 160, 292-310 (2010).
11. 2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229-1235 (2001). (Pubitemid 32995382)
12. Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).
13. Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011).
14. The International Multiple Sclerosis Genetics Consortium & the Wellcome Trust Case Control Consortium. Genetic risk and a primary role for cellmediated immune mechanisms in multiple sclerosis. Nature 476, 214-219 (2011).
15. Bossini-Castillo, L. et al. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum. Mol. Genet. 21, 926-933 (2012).
16. Li, X. et al. Divergent requirement for Gas and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets. J. Clin. Invest. 122, 963-973 (2012).
17. Mayr, B. & Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell. Biol. 2, 599-609 (2001). (Pubitemid 33674011)
18. Altarejos, J. Y. & Montminy, M. CREB and the CRTC-co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell. Biol. 12, 141-151 (2011).
19. Sasaki, T. et al. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron 69, 106-119 (2011).
20. Katoh, Y. et al. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J. 273, 2730-2748 (2006).
21. Screaton, R. A. et al. The CREB coactivator TORC2 functions as a calcium-and cAMP-sensitive coincidence detector. Cell 119, 61-74 (2004). (Pubitemid 39349320)
22. Horike, N. et al. Down-regulation of SIK2 expression promotes the melanogenic program in mice. Pigment Cell. Melanoma Res. 23, 809-819 (2010).
23. Szabo, S. J., Dighe, A. S., Gubler, U. & Murphy, K. M. Regulation of the interleukin (IL)-12R b2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185, 817-824 (1997). (Pubitemid 27119865)
24. + T cells. Nat. Immunol. 3, 549-508 (2002).
25. Watford, W. T. et al. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202, 139-156 (2004). (Pubitemid 39576910)
26. Skrenta, H., Yang, Y., Pestka, S. & Fathman, C. G. Ligand-independent down-regulation of ifn-g receptor 1 following tcr engagement. J. Immunol. 164, 3506-3511 (2000). (Pubitemid 30169801)
27. Schulz, E. G., Mariani, L., Radbruch, A. & Hofer, T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-g and interleukin-12. Immunity 30, 673-683 (2009).
28. Hirata, K. & Narumiya, S. Prostanoid Receptors. Chem. Rev. 111, 6209-6230 (2011).
29. Chang, J. T., Shevach, E. M. & Segal, B. M. Regulation of interleukin (IL)-12 receptor b2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J. Exp. Med. 189, 969-978 (1999). (Pubitemid 29149353)
30. Huang, S. et al. Immune response in mice that lack the interferon-g receptor. Science 259, 1742-1745 (1993). (Pubitemid 23114659)
31. H2 cytokines. Nat. Immunol. 2, 37-44 (2001). (Pubitemid 33704951)
32. Murray, A. J. Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal. 1, re4 (2008).
33. Bjorgo, E. et al. Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex. Mol. Cell. Biol. 30, 1660-1672 (2010).
34. Christensen, A. E. et al. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278, 35394-35402 (2003). (Pubitemid 37102308)
35. Ravnskjaer, K. et al. Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J. 26, 2880-2889 (2007). (Pubitemid 46975772)
36. Muraoka, M. et al. Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. Am. J. Physiol. Endocrinol. Metab. 296, E1430-E1439 (2009).
37. Takahama, Y. et al. Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene. Eur. J. Immunol. 28, 2159-2166 (1998). (Pubitemid 28321300)
38. Schneider, A. et al. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 40, 7-14 (2004). (Pubitemid 39655112)
39. 2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J. Immunol. 184, 5595-5603 (2010).
40. Vang, T. et al. Activation of the Cooh-Terminal Src Kinase (Csk) by camp-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193, 497-508 (2001).
41. + Type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165, 6783-6790 (2000). (Pubitemid 32001144)
42. Ostanin, D. V. et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G135-G146 (2009).
43. Stallmach, A. et al. Increased expression of interleukin-12 receptor b2 on lamina propria mononuclear cells of patients with active Crohn's disease. Int. J. Colorectal. Dis. 17, 303-310 (2002). (Pubitemid 36067764)
44. Kirman, I., Nielsen, O. H., Kjaersgaard, E. & Brynskov, J. Interleukin-2 receptor alpha and beta chain expression by circulating alpha beta and gamma delta T cells in inflammatory bowel disease. Dig. Dis. Sci. 40, 291-295 (1995).
45. Ochaion, A. et al. The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol. 258, 115-122 (2009).
46. 2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 107, 12233-12238 (2010).
47. Rathmell, J. C., Farkash, E. A., Gao, W. & Thompson, C. B. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167, 6869-6876 (2001). (Pubitemid 33144179)